
Joshua Milner
Director, Division of Pediatric Allergy, Immunology and Rheumatology · New York Presbyterian Hospital
Credentials: · · ·
History
PresentAllergy Division · New York Presbyterian Hospital
PresentAllergy Division · Columbia Univ Coll of Phys & Surgeons
PresentNew York Presbyterian Hospital · Columbia Univ Coll of Phys & Surgeons
2003–2005
1996–2000
Research
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
Science · 2020 · 1,856 citations
Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome
Nature · 2008 · First of 17 authors · 914 citations
Early-onset stroke and vasculopathy associated with mutations in ADA2
New England Journal of Medicine · 2014 · 651 citations

35 papers
- SH
32 papers
- KS
19 papers

13 papers

13 papers · 6 as a fellow
- DM
11 papers

9 papers
- JL
9 papers
Grants
- 2026–2031
National Institute of Allergy and Infectious Diseases · R01
PI · $821.4K · Columbia University Health Sciences
- 2025–2030
Novel Mechanisms of Genetic Errors of Immunity
National Institute of Allergy and Infectious Diseases · P01
Project lead · $968.7K · Washington University
- 2023–2028
New York Regional Inborn Errors of Immunity Resource Initiative League (NY-ROYAL)
National Institute of Allergy and Infectious Diseases · R24
Contact PI · $3.3M · Columbia University Health Sciences
- 2023–2028
Mechanistic Elucidation of Pathogenic CBM Complex Mutations Associated with Atopic Disease
National Institute of Allergy and Infectious Diseases · R01
PI · $2.8M · Henry m. Jackson Fdn for the Adv Mil/Med
Clinical trials
- 2020–2021
Glutamine Supplementation in People With Immune Dysregulation
Principal investigator · Withdrawn · Early phase 1
National Institute of Allergy and Infectious Diseases (NIAID)
- 2010–2027
- 2010–2015
A Pilot Study Using Anakinra/Kineret for the Treatment of Patients With Severe Atopic Dermatitis
Principal investigator · Terminated · Phase 1
National Institute of Allergy and Infectious Diseases (NIAID)

